HistoSonics - About the company
HistoSonics is an acquired company based in Ann Arbor (United States), founded in 2009 by Jim Bertolina and Christine Gibbons. It operates as an Ultrasound-based tissue ablation. HistoSonics has raised $566M in funding from investors like Venture Investors, Early Stage Partners and Hatteras Venture Partners, with last known valuation of $*****. The company has 16 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Carthera, Sound Blade Medical and Shende Medical.
Company Details
HistoSonics is developing Histotripsy technology, licensed from the University of Michigan. It is a non-invasive, image guided therapeutic ultrasound system that excises tissue. Uses pulsed sound waves to induce cavitation that mechanically destroys tissue, tumors and plaque at the cellular level. Application areas include cardiovascular, oncology, neurology and urology.
- Website
- histosonics.com
- Social
- Email ID
- *****@histosonics.com
- Registered Address
- Plymouth, Minnesota
Key Metrics
Founded Year
2009
Location
Ann Arbor, United States
Stage
Acquired
Total Funding
$566M in 11 rounds
Latest Funding Round
Last Known Valuation
$***** as on Aug 01, 2024
Investors
Ranked
1st among 16 active competitors
Employee Count
373 as on Mar 31, 2026
Exit Details
Acquired by K5 Global (Aug 07, 2025)
Legal entities associated with HistoSonics
HistoSonics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Histosonics, Inc Attn Christine CIN: 271236963 , United States, Active | Dec 31, 1999 | - | 198 (As on Dec 31, 2024) | - |
HistoSonics's acquisition details
HistoSonics got acquired by K5 Global, Bezos Expeditions and Wellington on Aug 07, 2025 at an acquisition amount of $2.25B. It was facilitated by Citi, Morgan Stanley, Fox Rothschild and 3 more.
Click here to take a look at HistoSonics's acquisition in detail
Sign up to download HistoSonics' company profile
HistoSonics's funding and investors
HistoSonics has raised a total funding of $566M over 11 rounds. Its first funding round was on Dec 16, 2009. Its latest funding round was a Series E round on Oct 16, 2025 for $*****. 2 investors participated in its latest round. HistoSonics has 23 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of HistoSonics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 16, 2025 | 3014376 | Series E | 2504474 | 5434297 | 8557328 | 3356207 |
Jul 31, 2024 | 5496616 | Series D | 6890458 | 1535919 | 6186229 | |
Dec 13, 2022 | 2743039 | Series D | 3341970 | 7873054 |
Access funding benchmarks and valuations. Sign up today!View details of HistoSonics's funding rounds and investors
HistoSonics' founders and board of directors
Founder? Claim ProfileThe founders of HistoSonics are Jim Bertolina and Christine Gibbons. Mike Blue is the CEO of HistoSonics.
Here are the details of HistoSonics' key team members:
- Jim Bertolina: Former Co-Founder of HistoSonics.
- Christine Gibbons: Former Co-Founder of HistoSonics.
View details of HistoSonics's Founder profiles and Board Members
HistoSonics' employee count trend
HistoSonics has 373 employees as of Mar 26. Here is HistoSonics's employee count trend over the years:
Uncover HistoSonics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HistoSonics's Competitors and alternates
Top competitors of HistoSonics include Carthera, Sound Blade Medical and Shende Medical. Here is the list of Top 10 competitors of HistoSonics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | HistoSonics 2009, Ann Arbor (United States), Acquired | Ultrasound-based tissue ablation | $566M | 63/100 | |
2nd | Devices focused on the treatment of brain tumors | $55.1M | 56/100 | ||
3rd | Sound Blade Medical 2023, Halifax (Canada), Series A | Developer of a compact ultrasound therapy platform for non-invasive treatment of various pathologies | $16.5M | 55/100 | |
4th |  Shende Medical 2013, Xuhui (China), Series C | Provider of ultrasound therapy system for malignant tumors | $15.7M | 51/100 | |
5th | OxSonics 2013, Oxford (United Kingdom), Series B | Developer of ultrasound technologies to enhance anticancer drug delivery to solid tumors | $15.9M | 41/100 | |
6th |  SONIRE Therapeutics 2020, Tokyo (Japan), Series B | Developer of high intensity focused ultrasound treatment systems | $17M | 37/100 | |
7th | IMBiotechnologies 2008, Edmonton (Canada), Seed | Manufacturer of embolotherapy products for the treatment of cancer | $129K | - | 32/100 |
8th | Gendel Limited 1998, Coleraine (United Kingdom), Deadpooled | Ultrasound and electric field technology for solid tumour treatment | $6.42M | 30/100 | |
9th | FUS Instruments 2009, Toronto (Canada), Funding Raised | High intensity focused ultrasound devices | - | 29/100 | |
10th | Provides technology for radiotherapy for cancer patients | - | - | 28/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on HistoSonics's competitors? Click here to see the top ones
HistoSonics's Investments and acquisitions
HistoSonics has made no investments or acquisitions yet.
Reports related to HistoSonics
Here is the latest report on HistoSonics's sector:
News related to HistoSonics
Filter this listMedia has covered HistoSonics for a total of 20 events in the last 1 year, 9 of them have been about company updates and 2 about partnerships.
•
•
HistoSonics Treats First Patients with Edison System for BPHBusinessFortNight•Mar 30, 2026•HistoSonics
•
Synektik signs agreement with US-based HistoSonics to distribute cancer therapy equipmentgospodarka.sos.pl•Jan 08, 2026•Synektik, HistoSonics
•
HistoSonics Announces Oversubscribed $250 Million Growth Financingintelligence360•Nov 11, 2025•K5 Global, HistoSonics, Wellington, Bezos Expeditions and 1 other
•
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor TreatmentKorea Newswire•Oct 23, 2025•Elevance Health, HistoSonics
•
HistoSonics Closes $250M FinancingFinSMEs•Oct 16, 2025•HistoSonics, Founders Fund, , Orrick and 3 others
•
•
K5 Global Leads $2.25 Billion Acquisition of Majority Stake in HistoSonicsGlobal Legal Chronicle•Sep 17, 2025•Fox Rothschild, K5 Global, HistoSonics, Orrick
•
HistoSonics Acquired by Investor ConsortiumEvtoday•Aug 07, 2025•K5 Global, HistoSonics, Wellington, Bezos Expeditions
•
Lenskart Files DRHP with SEBI for ₹2,150 Crore IPOLivemint•Jul 29, 2025•Lenskart, SoftBank, Kedaara, Temasek and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about HistoSonics
Explore our recently published companies
- Sidvin Core-Tech - Bengaluru based, 2000 founded, Unfunded company
- Janina-Wagner - Germany based, Unfunded company
- Xn--Licht-Krper-Heilung-W6B - Germany based, Unfunded company
- Ism-D - Unfunded company
- Evanshomes - Unfunded company
- Innovationfactoryni - United Kingdom based, 2016 founded, Public company
